Citations (0)
Keep up to date with the latest research on this topic with citation updates for this article.
Acta Oncologica
Volume 62, 2023 - Issue 4
Original Articles: Clinical Oncology
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study
Ahmet Bilicia Istanbul Medipol University Faculty of Medicine, Istanbul, TurkeyCorrespondence[email protected]
https://orcid.org/0000-0002-0443-6966View further author information
https://orcid.org/0000-0002-0443-6966View further author information, , , , , , Erdem Cubukcuf Uludag University Faculty of Medicine, Bursa, Turkeyhttps://orcid.org/0000-0002-0070-0889View further author information
https://orcid.org/0000-0002-0070-0889View further author information, , , , , Burcu Cakark Ege University Faculty of Medicine, Izmir, Turkeyhttps://orcid.org/0000-0003-3790-791XView further author information
https://orcid.org/0000-0003-3790-791XView further author information, , , , Sema Sezgin Goksun Akdeniz University Faculty of Medicine, Antalya, Turkeyhttps://orcid.org/0000-0002-8026-764XView further author information
https://orcid.org/0000-0002-8026-764XView further author information, , , Mahmut Gumusq Istanbul Medeniyet University Faculty of Medicine, Istanbul, Turkeyhttps://orcid.org/0000-0003-3550-9993View further author information
https://orcid.org/0000-0003-3550-9993View further author information, , & show all